Crescent Capital BDC (CCAP)
(Delayed Data from NSDQ)
$18.36 USD
+0.08 (0.44%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $18.33 -0.03 (-0.16%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$18.36 USD
+0.08 (0.44%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $18.33 -0.03 (-0.16%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum D VGM
Zacks News
Fidelity National (FNF) Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Fidelity National (FNF) Q4 earnings likely to benefit from higher direct premium, agency premiums as well as escrow, title-related and other fees.
Lemonade (LMND) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Lemonade's (LMND) Q4 results are likely to reflect benefits from the diversification of business mix to higher premium products and multiple policies of customers.
ProAssurance (PRA) to Post Q4 Earnings: What You Need to Know
by Zacks Equity Research
ProAssurance's (PRA) fourth-quarter results are likely to reflect increased net investment income and premiums earned.
BGC Partners (BGCP) Q4 Earnings Match Estimates
by Zacks Equity Research
BGC Partners (BGCP) delivered earnings and revenue surprises of 0% and 5.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Crescent Capital BDC (CCAP) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Crescent Capital BDC (CCAP) delivered earnings and revenue surprises of 14.29% and 10.95%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Crescent Capital BDC (CCAP) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Crescent Capital BDC (CCAP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Crescent Capital BDC (CCAP) Q2 Earnings Lag Estimates
by Zacks Equity Research
Crescent Capital BDC (CCAP) delivered earnings and revenue surprises of -13.33% and 12.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Crescent Capital BDC (CCAP) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Crescent Capital BDC (CCAP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Crescent Capital BDC (CCAP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Crescent Capital BDC (CCAP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Crescent Capital BDC (CCAP) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Crescent Capital BDC (CCAP) delivered earnings and revenue surprises of 2.17% and 3.32%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Crescent Capital BDC (CCAP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Crescent Capital BDC (CCAP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
All You Need to Know About Crescent Capital BDC, Inc. (CCAP) Rating Upgrade to Buy
by Zacks Equity Research
Crescent Capital BDC, Inc. (CCAP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The Zacks Analyst Blog Highlights: Galiano Gold, Fortinet, Meridian Bioscience, Crescent Capital BDC and NextEra Energy
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Galiano Gold, Fortinet, Meridian Bioscience, Crescent Capital BDC and NextEra Energy
5 Stocks to Wade Through Hurdles in Second-Half 2020
by Sreoshi Bera
Keeping the coronavirus impact in mind, we have shortlisted five stocks that can return well on investment in the second half of 2020.
Medallion (MFIN) Soars: Stock Moves 9.1% Higher
by Zacks Equity Research
Medallion (MFIN) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Near-Term Outlook Dim for SBIC & Commercial Finance Industry
by Swayta Shah
Lower interest rates, weak loan demand and coronavirus-related economic slowdown are likely to hurt the SBIC & commercial finance industry's near-term prospects.